Purchases and Sales Made in Q4 2023 in Pacira Bio Sciences, Inc. (PCRX)
This table provides information about the institutional ownership of Pacira Bio Sciences, Inc. (PCRX) during Q4 2023. The information is specifically focused on institutions that hold shares of Pacira BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-25.5K- 71.91% |
$672K - $876K
|
9.97K
$206K
|
|
|
Feb 13, 2024
Q4 2023
|
Stephens Investment Management Group LLC
|
SELL
|
- |
-25.7K- 1.91% |
$675K - $880K
|
1.32M
$27.2M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-36K- 30.59% |
$948K - $1.24M
|
81.7K
$1.69M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-36.6K- 71.66% |
$964K - $1.26M
|
14.5K
$299K
|
|
|
Feb 13, 2024
Q4 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-45.9K- 6.88% |
$1.21M - $1.58M
|
622K
$12.8M
|
|
|
Feb 14, 2024
Q4 2023
|
Gagnon Advisors, LLC
|
SELL
|
- |
-46.9K- 26.03% |
$1.24M - $1.61M
|
133K
$2.75M
|
|
|
Feb 13, 2024
Q4 2023
|
Loomis Sayles & CO L P
|
SELL
|
- |
-48.2K- 12.85% |
$1.27M - $1.65M
|
327K
$6.74M
|
|
|
Feb 07, 2024
Q4 2023
|
Boston Partners
Boston, MA |
SELL
|
- |
-50.7K- 46.72% |
$1.33M - $1.74M
|
57.8K
$1.19M
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-61K- 62.96% |
$1.61M - $2.09M
|
35.9K
$741K
|
|
|
Jul 31, 2024
Q4 2023
|
Rothschild Investment LLC
Chicago, IL |
SELL
|
- |
-72.4K- 99.15% |
$1.9M - $2.48M
|
621
$12.8K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-74.8K- 89.77% |
$1.97M - $2.57M
|
8.53K
$176K
|
|
|
Feb 14, 2024
Q4 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-94.1K- 71.25% |
$2.48M - $3.23M
|
37.9K
$783K
|
|
|
Feb 13, 2024
Q4 2023
|
Neumeier Poma Investment Counsel LLC
|
SELL
|
- |
-98.5K- 37.06% |
$2.59M - $3.38M
|
167K
$3.45M
|
|
|
Feb 08, 2024
Q4 2023
|
First Eagle Investment Management, LLC
|
SELL
|
- |
-105K- 50.35% |
$2.75M - $3.59M
|
103K
$2.13M
|
|
|
Feb 13, 2024
Q4 2023
|
Public Employees Retirement Association Of Colorado
Denver, CO |
SELL
|
- |
-120K- 94.63% |
$3.16M - $4.12M
|
6.82K
$141K
|
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-124K- 35.36% |
$3.26M - $4.25M
|
226K
$4.67M
|
|
|
Feb 14, 2024
Q4 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-278K- 16.71% |
$7.31M - $9.53M
|
1.38M
$28.6M
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-435K- 47.57% |
$11.5M - $14.9M
|
480K
$9.9M
|
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-574K- 35.05% |
$15.1M - $19.7M
|
1.06M
$21.9M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-595K- 80.89% |
$15.7M - $20.4M
|
141K
$2.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-952K- 78.65% |
$25.1M - $32.7M
|
258K
$5.33M
|